التفاصيل البيبلوغرافية
| العنوان: |
Comparative safety analysis of anti-interleukin-4/interleukin-13 inhibitors and Janus Kinase inhibitors in atopic dermatitis. |
| المؤلفون: |
Bao A; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Su HJ; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland., Wan J; Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: jwan7@jhmi.edu. |
| المصدر: |
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Jul 05. Date of Electronic Publication: 2024 Jul 05. |
| Publication Model: |
Ahead of Print |
| نوع المنشور: |
Journal Article |
| اللغة: |
English |
| بيانات الدورية: |
Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE |
| أسماء مطبوعة: |
Original Publication: St. Louis, Mo., Mosby |
| مستخلص: |
Competing Interests: Conflicts of interest Joy Wan has received research and fellowship funding from Pfizer (paid to Johns Hopkins University) and has served on a data monitoring committee for Sun Pharmaceuticals and as a consultant for Janssen, receiving honoraria. Aaron Bao and Hsing-Jou Su have no conflicts to disclose. |
| فهرسة مساهمة: |
Keywords: atopic dermatitis; atopic eczema; epidemiology; immunobiologics; immunomodulators; inflammation/inflammatory; outcomes (see also health services research) |
| تواريخ الأحداث: |
Date Created: 20240706 Latest Revision: 20240724 |
| رمز التحديث: |
20240725 |
| DOI: |
10.1016/j.jaad.2024.06.064 |
| PMID: |
38971182 |
| قاعدة البيانات: |
MEDLINE |
Full Text via ClinicalKey 
Full Text Finder